EndomeTRIO: The endometrium matters

EndomeTRIO
Benefits
Indications

Why does the endometrium matter?

The endometrium has been noted as a key factor for a healthy pregnancy in recent scientific studies. In fact, 20% of infertility is caused by the endometrial factor. [reference?]

Since 2014, Igenomix has been conducting a deep line of research to understand the role of the endometrial factor in recurrent implantation failure patients.

Our recent publications in the American Journal of Obstetrics and Gynecology (AJOG) demonstrate a new dimension of endometrial health that can improve your patient’s reproductive prognosis.

Which tests are included in EndomeTRIO?

ERA

The ERA test evaluates the receptivity of the endometrium to determine if, at the time of biopsy, the uterine lining is receptive to embryo implantation. This information allows us to determine the ideal time for a personalised embryo transfer (pET). The ERA test resulted in a 73% pregnancy rate in patients with implantation failure.

More info

EMMA

EMMA (Endometrial Microbiome Metagenomic Analysis) is a screening test to evaluate the endometrium at the microbiological level, improving clinical management of infertile patients.
By analysing the endometrial microbiome, EMMA determines whether the uterine microbial environment is optimal for embryo implantation.
EMMA provides information about the ten most abundant bacteria in the endometrium, recommending embryo transfer or appropriate treatment, depending on results.

More info

ALICE (Analysis of Infectious Chronic Endometritis) is a diagnostic test to detect the bacteria causing chronic endometritis (CE), a condition that is associated with infertility.
Independent studies show that this condition affects up to 30% of infertile patients, and in cases of repeated implantation failure or recurrent pregnancy loss, this can rise to 66%*.
ALICE identifies the most common bacteria causing CE and helps clinicians to recommend appropriate antibiotic and probiotic treatments.

More info

Who should use EndomeTRIO Analysis?

Women who have experienced implantation failure with morphologically good quality embryos
Women with a history of recurrent pregnancy loss
Women with a morphologically normal uterus and normal endometrial thickness (≥ 6 mm), where the physical features of the uterus and endometrium are unlikely to be the problem
Women with Chronic Endometritis

Methodology:

Only a single endometrial biopsy is needed to perform the combined ERA+EMMA+ALICE test, EndomeTRIO.

How should I and send the sample?

An endometrial biopsy taken from the uterine fundus must be immediately place into an ERA cryotube, shaken and stored in a refrigerator (4-8°C/ 39-46°F) for at least 4 hours.
Samples are sent at room temperature(<35ºC/95ºF) accompanied with the patient´s informed consent and a completed requisition form.

Test Limitations

Patients planning an assisted reproduction treatment
ERA test limitations
EMMA test limitations
ALICE test limitations

Documentation

Specialists’ documents

Clinical Sheet

Download

Brochure

Download

EndomeTrio Manual

Download

Scientific evidence

Relevant related studies:

Cicinelli et al. Reprod Sci 2014; 21(5):640-7.

Cicinelli et al. Hum Reprod. 2015; 30(2):323-30.

Moreno I. et tal. Am J Obstet Gynecol, 2018, 218(6):602-602.

Moreno I. et tal. Am J Obstet Gynecol. 2016;215(6):684-703.

Igenomix and fertility

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix

Other services

ERA

Evaluates the endometrial receptivity

More information

EMMA

Evaluates the endometrium at the microbiological level

More information

ALICE

Detects the bacteria causing chronic endometritis

More information

Sex selection and Sex determination, before and after conception is prohibited and punishable under PC & PNDT act no. 57 of 1994

Igenomix is in the media

IGENOMIX has not affiliated any news outlet or publication identified above. News coverage does not constitute an endorsement of IGENOMIX or its products

EMMA + ALICE + ERA

A better understanding of endometrial health to improve you patient’s reproductive prognosis

30% of infertile women
have pathogenic bacteria

Why does the endometrium matter?

Which tests are included in EndomeTRIO?

ERA

EMMA

Who should use EndomeTRIO Analysis?

Methodology:

How should I and send the sample?

Test Limitations

Clinical Sheet

Brochure

EndomeTrio Manual

Relevant related studies:

Can we help you?

Igenomix and fertility

ERA

EMMA

ALICE

Igenomix is in the media

A new dimension of endometrial health to improve the reproductive prognosis of your patients.

EMMA + ALICE + ERA

A better understanding of endometrial health to improve you patient’s reproductive prognosis

30% of infertile women have pathogenic bacteria

Why does the endometrium matter?

Which tests are included in EndomeTRIO?

ERA

EMMA

Who should use EndomeTRIO Analysis?

Methodology:

How should I and send the sample?

Test Limitations

Clinical Sheet

Brochure

EndomeTrio Manual

Relevant related studies:

Can we help you?

Igenomix and fertility

Other services

ERA

EMMA

ALICE

Igenomix is in the media

30% of infertile women
have pathogenic bacteria